Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.

PLoS neglected tropical diseases - 1 Sept 2021

Taylor Walter R J, Kim Saorin, Kheng Sim, Muth Sinoun, Tor Pety, Christophel Eva, Mukaka Mavuto, Kerleguer Alexandra, Luzzatto Lucio, Baird J Kevin, Menard Didier

Abstract excerpt

BACKGROUND: Acute Plasmodium vivax malaria is associated with haemolysis, bone marrow suppression, reticulocytopenia, and post-treatment reticulocytosis leading to haemoglobin recovery. Little is known how malaria affects glucose-6-phosphate dehydrogenase (G6PD) activity and whether changes in activity when patients present may lead qualitative tests, like the fluorescent spot test (FST), to misdiagnose G6PD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials
Share to Cambodia

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Erythrocytes

Share to Glucosephosphate Dehydrogenase

Share to Hemoglobins

Share to Hemolysis

Share to Malaria, Vivax

Source

Open in PubMed Open full text

Identifiers

PMID: 34495956
DOI: 10.1371/journal.pntd.0009690
PMCID: PMC8452019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.PMID 34495956Read ↗

Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.Semantic proximity Read ↗

G6PD deficiency: global distribution, genetic variants and primaquine therapy.Semantic proximity Read ↗

The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects.Semantic proximity Read ↗

Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials.Semantic proximity Read ↗

Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, BangladeshSemantic proximity Read ↗

Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria.Semantic proximity Read ↗

G6PD deficiency in malaria endemic areas of Nepal.Semantic proximity Read ↗

Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: implications for treatment policy in the region.Semantic proximity Read ↗

Single Low Dose Primaquine (0.25mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient SubjectsSemantic proximity Read ↗

Pharmacometric assessment of primaquine induced haemolysis in glucose-6-phosphate dehydrogenase deficiencySemantic proximity Read ↗

G6<scp>PD</scp> deficiency: a classic example of pharmacogenetics with on‐going clinical implicationsSemantic proximity Read ↗

Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.